Prix
Questions fréquentes
Quelle est la capitalisation boursière de Amneal ?
Quel est le bénéfice par action (BPA) de Amneal ?
Quelles sont les évaluations des analystes et le prix cible de l'action Amneal ?
Quel est le chiffre d'affaires de Amneal sur les douze derniers mois ?
Quel est l'EBITDA de Amneal ?
Quel est le flux de trésorerie disponible de Amneal ?
Quel est le bêta à 5 ans de l'action Amneal ?
Combien d'employés compte Amneal, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Amneal ?
Finances
Capitalisation boursière
2,85 Md $USbêta sur 5 ans
1,15BPA (TTM)
-0,684 $USFree Float
129,11 MRecettes (TTM)
2,68 Md $USEBITDA (TTM)
546,00 M $USCash-flow disponible (TTM)
229,23 M $USCotation
Notes des analystes
L'objectif de prix est de 8,25 $US et l'action est analysée par 4 analystes.
Acheter
4
Hold
0
Vendre
0
Informations
Amneal Pharmaceuticals, Inc. is a global pharmaceutical company, which develops, manufactures, markets and distributes a portfolio of essential medicines. Its Generics segment includes a retail and institutional portfolio of over 270 product families covering a range of dosage forms and delivery systems, including both immediate and extended-release oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmic, films, transdermal patches and topicals. Its Specialty segment is engaged in the development, promotion, sale and distribution of branded pharmaceutical products, with a focus on products addressing central nervous system disorders, including Parkinson’s disease and endocrine disorders. Its AvKARE segment provides pharmaceuticals, medical and surgical products and services primarily to governmental agencies, predominantly focused on the U.S. Department of Defense and the U.S. Department of Veterans Affairs.
7 700
Biotechnology & Drugs
Soins de santé
Identifiant
ISIN
Ticker primaire